1. Home
  2. BIO vs BSAC Comparison

BIO vs BSAC Comparison

Compare BIO & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • BSAC
  • Stock Information
  • Founded
  • BIO 1952
  • BSAC 1977
  • Country
  • BIO United States
  • BSAC Chile
  • Employees
  • BIO N/A
  • BSAC N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • BSAC Commercial Banks
  • Sector
  • BIO Industrials
  • BSAC Finance
  • Exchange
  • BIO Nasdaq
  • BSAC Nasdaq
  • Market Cap
  • BIO 7.7B
  • BSAC 12.4B
  • IPO Year
  • BIO N/A
  • BSAC 1994
  • Fundamental
  • Price
  • BIO $305.38
  • BSAC $27.25
  • Analyst Decision
  • BIO Strong Buy
  • BSAC Hold
  • Analyst Count
  • BIO 4
  • BSAC 2
  • Target Price
  • BIO $333.50
  • BSAC $22.50
  • AVG Volume (30 Days)
  • BIO 199.7K
  • BSAC 289.2K
  • Earning Date
  • BIO 10-30-2025
  • BSAC 10-30-2025
  • Dividend Yield
  • BIO N/A
  • BSAC 3.71%
  • EPS Growth
  • BIO N/A
  • BSAC 42.17
  • EPS
  • BIO 11.49
  • BSAC 0.01
  • Revenue
  • BIO $2,554,200,000.00
  • BSAC $2,427,252,037.00
  • Revenue This Year
  • BIO $2.05
  • BSAC $41.14
  • Revenue Next Year
  • BIO $2.86
  • BSAC $5.30
  • P/E Ratio
  • BIO $26.61
  • BSAC $11.24
  • Revenue Growth
  • BIO N/A
  • BSAC 20.73
  • 52 Week Low
  • BIO $211.43
  • BSAC $18.19
  • 52 Week High
  • BIO $387.99
  • BSAC $27.30
  • Technical
  • Relative Strength Index (RSI)
  • BIO 59.71
  • BSAC 65.50
  • Support Level
  • BIO $292.56
  • BSAC $26.27
  • Resistance Level
  • BIO $305.12
  • BSAC $26.98
  • Average True Range (ATR)
  • BIO 9.64
  • BSAC 0.43
  • MACD
  • BIO 1.34
  • BSAC -0.01
  • Stochastic Oscillator
  • BIO 85.94
  • BSAC 96.10

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About BSAC Banco Santander - Chile ADS

Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.

Share on Social Networks: